Friulchem SpA
MIL:FCM

Watchlist Manager
Friulchem SpA Logo
Friulchem SpA
MIL:FCM
Watchlist
Price: 0.76 EUR -1.3% Market Closed
Market Cap: 4.6m EUR
Have any thoughts about
Friulchem SpA?
Write Note

Relative Value

The Relative Value of one FCM stock under the Base Case scenario is 4.33 EUR. Compared to the current market price of 0.76 EUR, Friulchem SpA is Undervalued by 82%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FCM Relative Value
Base Case
4.33 EUR
Undervaluation 82%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
89
Median 3Y
0.2
Median 5Y
0.2
Industry
2.6
Forward
0.1
vs History
vs Industry
1
Median 3Y
61
Median 5Y
-18.7
Industry
23
Forward
-75.2
vs History
53
vs Industry
26
Median 3Y
1.6
Median 5Y
0.4
Industry
17.8
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-2.4
Industry
25.4
vs History
98
vs Industry
69
Median 3Y
0.6
Median 5Y
0.8
Industry
2.2
vs History
30
vs Industry
85
Median 3Y
0.3
Median 5Y
0.4
Industry
2.8
Forward
0.4
vs History
39
vs Industry
64
Median 3Y
1.6
Median 5Y
1.9
Industry
5.4
vs History
30
vs Industry
41
Median 3Y
5.3
Median 5Y
5.4
Industry
13.7
Forward
6.5
vs History
42
vs Industry
22
Median 3Y
14.9
Median 5Y
11.8
Industry
17.2
Forward
16.6
vs History
53
vs Industry
31
Median 3Y
2.4
Median 5Y
0.9
Industry
16.5
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-9.2
Industry
19.3
vs History
39
vs Industry
74
Median 3Y
0.4
Median 5Y
0.5
Industry
2

Multiples Across Competitors

FCM Competitors Multiples
Friulchem SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Friulchem SpA
MIL:FCM
4.6m EUR 0.2 -18.8 7 15
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IT
Friulchem SpA
MIL:FCM
Average P/E: 33.1
Negative Multiple: -18.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top